Dr. Carl J. Christel is currently the Head of the US site at Revvity Gene Delivery GmbH, a position held since January 2023. Prior to this role, Dr. Christel served in various leadership capacities at SIRION Biotech GmbH from January 2013 to September 2023, including Vice President of US Operations and Global Marketing Director & Sales USA, with responsibilities encompassing sales, marketing, and customer project management. Dr. Christel's expertise is underpinned by a strong research background as a Post-Doc Scholar at The University of Iowa Health Care, focusing on molecular physiology and cardiology, and a PhD in Biology from Technische Universität München.